Eyes
Naphazoline + pheniramine (ophthalmic)
Antihistamine (H1) First Generation + Vasoconstrictor
Other names: Naphcon-A, Opcon-A, Visine
Wait
48 hours
after the first dose
The FAA's MedGuide lists naphazoline + pheniramine (ophthalmic) (Naphcon-A, Opcon-A, Visine) as allowed, for itching or eye redness, with a wait of 48 hours after the first dose and none after later doses or after the final dose, used per label directions.
Track your medicationsMore detail: naphazoline + pheniramine (ophthalmic)The rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
- 48 hours after the first dose: ground observation
Show the FAA's words: naphazoline + pheniramine (ophthalmic)The official FAA wording: three passages, each with its document and dateOpen
Generic: naphazoline + pheniramine (ophthalmic)
Brand Name: Naphcon-A; Opcon-A; Visine
Drug Class: Antihistamine (H1) First Generation + Vasoconstrictor
Underlying Condition: Itching; Eye redness
Use: ALLOW
INITIAL Wait Time (after first dose): 48 hours
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: Per label directions
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.